Published in Gut on February 01, 1998
Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut (2000) 2.86
Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut (2005) 1.70
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut (2005) 1.26
Acute myeloid leukemia developing in patients with autoimmune diseases. Haematologica (2011) 1.13
No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. Clin Gastroenterol Hepatol (2011) 1.05
The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs. Hered Cancer Clin Pract (2005) 1.04
Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001. Gut (2004) 0.98
Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease. Gut (2004) 0.97
Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis. Inflamm Bowel Dis (2013) 0.96
Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut (2006) 0.95
Inflammatory bowel disease of the elderly: a wake-up call. Gastroenterol Hepatol (N Y) (2008) 0.89
Clinical course and prognosis in ulcerative colitis: results from population-based and observational studies. Ann Gastroenterol (2014) 0.88
Inflammatory bowel disease cause-specific mortality: a primer for clinicians. Inflamm Bowel Dis (2014) 0.84
Clinical epidemiology--how important now? Gut (2005) 0.82
Methodology for high-quality studies on course and prognosis of inflammatory bowel disease. World J Gastroenterol (2012) 0.76
Does smoking reduce infliximab's effectiveness against Crohn's disease? Can J Gastroenterol (2009) 0.76
Colitic cancer developed after introduction of azathioprine. Dig Dis Sci (2004) 0.75
Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med (1990) 6.87
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology (1992) 2.86
Smoking habits and recurrence in Crohn's disease. Gastroenterology (1994) 2.30
Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut (1994) 2.12
Cigarette smoking and inflammatory bowel disease. Gastroenterology (1987) 2.04
Mortality in Crohn's disease. Gastroenterology (1981) 1.95
Cancer morbidity in ulcerative colitis. Gut (1982) 1.82
Crohn's disease and cancer: a population-based cohort study. Gastroenterology (1994) 1.77
Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology (1993) 1.74
Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology (1992) 1.65
Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology (1994) 1.64
Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology (1996) 1.51
Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol (1987) 1.34
Epidemiology of inflammatory bowel disease: an update. Scand J Gastroenterol (1996) 1.29
Cancer in patients with ulcerative colitis. Int J Cancer (1995) 1.28
Incidence of colorectal cancer and all cause mortality in non-selected patients with ulcerative colitis and indeterminate colitis in Malmö, Sweden. Int J Colorectal Dis (1995) 1.18
Malignancy in ulcerative colitis. Scand J Gastroenterol (1989) 1.11
Mortality from Crohn's disease in Leicestershire, 1972-1989: an epidemiological community based study. Gut (1992) 1.07
A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). Scand J Gastroenterol (1996) 1.06
Mortality and causes of death in Crohn's disease. Review of 50 years' experience in Leiden University Hospital. Gut (1990) 1.04
Mortality in patients with ulcerative colitis in Leicestershire, 1972-1989. An epidemiological study. Dig Dis Sci (1993) 1.04
Prognosis and mortality of ulcerative colitis in Stockholm County, 1955-1979. Scand J Gastroenterol (1987) 0.94
Mortality in patients with Crohn's disease. Scand J Gastroenterol (1996) 0.89
Population-based studies of IBD incidence in Italy and capture-recapture methods. Int J Epidemiol (1997) 0.88
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (2003) 3.24
Randomised clinical trial: low-volume bowel preparation for colonoscopy - a comparison between two different PEG-based formulations. Aliment Pharmacol Ther (2012) 2.28
Dietary intakes and food sources of phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-hour dietary recall cohort. Eur J Clin Nutr (2012) 2.08
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab (1999) 1.92
Clinical characteristics and overall survival in genitourinary sarcomas treated with curative intent: a multicenter study. Eur Urol (2004) 1.56
Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. Eur Heart J (1996) 1.56
Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index. Thyroid (2000) 1.52
Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology (2000) 1.50
Heterogeneous expression of cyclooxygenase-2 and inducible nitric oxide synthase within colorectal tumors: correlation with tumor angiogenesis. Dig Liver Dis (2009) 1.47
Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis. Eur J Clin Nutr (2012) 1.46
Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy. N Engl J Med (1982) 1.46
Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial. Dig Liver Dis (2002) 1.44
Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev (1994) 1.42
A capture-recapture estimate of inflammatory bowel disease prevalence: the Florence population-based study. Ital J Gastroenterol Hepatol (1998) 1.39
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer (2006) 1.33
RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab (2001) 1.31
Association between dietary meat consumption and incident type 2 diabetes: the EPIC-InterAct study. Diabetologia (2012) 1.29
Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2011) 1.27
Haematopoietic cancer and medical history: a multicentre case control study. J Epidemiol Community Health (2000) 1.27
Patterns of alcohol consumption in 10 European countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) project. Public Health Nutr (2002) 1.26
Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels. J Clin Endocrinol Metab (2007) 1.25
Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women. Am J Ind Med (1999) 1.23
The influence of new technologies on laparoscopic adrenalectomy: our personal experience with 91 patients. Surg Endosc (2002) 1.23
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer (2008) 1.22
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther (1994) 1.22
Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res (1997) 1.19
Meat consumption in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts: results from 24-hour dietary recalls. Public Health Nutr (2002) 1.17
Reproductive history and gastric cancer among post-menopausal women. Int J Cancer (1994) 1.16
Diet, metabolic polymorphisms and dna adducts: the EPIC-Italy cross-sectional study. Int J Cancer (2000) 1.16
Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterology (1995) 1.16
Decreased suppressor T-lymphocytes in autoimmune thyroid diseases detected by monoclonal antibodies. J Clin Endocrinol Metab (1982) 1.15
N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression. Thyroid (2000) 1.14
Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma. Surgery (1989) 1.13
DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int J Cancer (2001) 1.12
Red meat, family history, and increased risk of gastric cancer with microsatellite instability. Cancer Res (2001) 1.09
Modified Mediterranean diet and survival after myocardial infarction: the EPIC-Elderly study. Eur J Epidemiol (2007) 1.06
A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). Scand J Gastroenterol (1996) 1.06
First direct detection of rickettsial pathogens and a new rickettsia, 'Candidatus Rickettsia barbariae', in ticks from Sardinia, Italy. Clin Microbiol Infect (2008) 1.05
Delayed infection, family size and malignant lymphomas. J Epidemiol Community Health (2000) 1.05
Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol (1998) 1.05
A multicenter case-control study in Italy on hematolymphopoietic neoplasms and occupation. Epidemiology (2001) 1.04
Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am J Gastroenterol (2005) 1.02
Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. J Clin Endocrinol Metab (1996) 1.02
Dietary glycaemic index and glycaemic load in the European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr (2009) 1.00
The impact of young age on breast cancer outcome. Eur J Surg Oncol (2010) 1.00
Dietary and familial determinants of 10-year survival among patients with gastric carcinoma. Cancer (2000) 1.00
Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma. Mod Pathol (1996) 0.99
Unsuspected parathyroid cysts diagnosed by measurement of thyroglobulin and parathyroid hormone concentrations in fluid aspirates. Ann Intern Med (1985) 0.98
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J Clin Endocrinol Metab (1996) 0.98
Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001. Gut (2004) 0.98
Eating out, weight and weight gain. A cross-sectional and prospective analysis in the context of the EPIC-PANACEA study. Int J Obes (Lond) (2010) 0.97
Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism. J Endocrinol Invest (2006) 0.97
The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma. J Endocrinol Invest (2011) 0.97
Interleukin-6 release from human abdominal adipose cells is regulated by thyroid-stimulating hormone: effect of adipocyte differentiation and anatomic depot. Am J Physiol Endocrinol Metab (2006) 0.97
131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study. J Clin Endocrinol Metab (2001) 0.97
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal. J Clin Endocrinol Metab (2009) 0.96
Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis. Am J Gastroenterol (1994) 0.95
Dietary glycaemic index, glycaemic load and subsequent changes of weight and waist circumference in European men and women. Int J Obes (Lond) (2009) 0.95
A retrospective study on burden of human echinococcosis based on Hospital Discharge Records from 2001 to 2009 in Sardinia, Italy. Acta Trop (2012) 0.94
Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies. Mult Scler (1999) 0.94
Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study. Aliment Pharmacol Ther (2003) 0.93
Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression. Br J Cancer (1997) 0.93
Trends in self-reported past alcoholic beverage consumption and ethanol intake from 1950 to 1995 observed in eight European countries participating in the European Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 0.92
Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. Am J Gastroenterol (1997) 0.92
Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clin Endocrinol (Oxf) (1985) 0.92
Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis. Scand J Gastroenterol (1996) 0.92
Human thyroglobulin reference material (CRM 457). 2nd Part: Physicochemical characterization and certification. Ann Biol Clin (Paris) (1996) 0.92
Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH. Eur J Endocrinol (2001) 0.91
Smoking and hematolymphopoietic malignancies. Cancer Causes Control (2001) 0.90
[Thyroid carcinoma in a thyroglossal duct cyst: tumor resection alone or a total thyroidectomy?]. Ann Chir (1998) 0.90
131I therapy for elevated thyroglobulin levels. Thyroid (1997) 0.90
Thyroid cancer in children and adolescents. Surgery (1988) 0.90
Suppression of Fas expression and down-regulation of Fas ligand in highly aggressive human thyroid carcinoma. Lab Invest (2000) 0.89
Thyroid function modulates thymic endocrine activity. J Clin Endocrinol Metab (1986) 0.89
Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema. Dig Dis Sci (1993) 0.89
Interference of serum thyroglobulin in the radioassay for serum antithyroglobulin antibodies. J Clin Endocrinol Metab (1977) 0.89
Studies of immunoglobulin synthesis in cultures of peripheral T and B lymphocytes: reduced T-suppressor cell activity in Graves' disease. Clin Endocrinol (Oxf) (1983) 0.89
TnphoA Salmonella abortusovis mutants unable to adhere to epithelial cells and with reduced virulence in mice. Infect Immun (1993) 0.88
5-Aminosalicylic acid in pregnancy: clinical report. Ital J Gastroenterol (1994) 0.88